search
Back to results

Deprescribing for Older Adults After Hospital Discharge in Home Health Care

Primary Purpose

Polypharmacy

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
HomeMed
Sponsored by
University of Rochester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Polypharmacy

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Patient Inclusion Criteria: 65 years of age and older currently hospitalized or having been hospitalized in the previous 2 weeks having a discharge disposition of home with a referral to receive HHC services from URMHC, or currently receiving HHC services from URMHC taking more than 10 regular medications daily having a primary care provider who is in the URMC system Ability to self-consent English-speaking Patient Exclusion Criteria: end-of-life prognosis in the following 6 months currently receiving hospice care, end-of-life care, or palliative care conditions that impact the receipt of the intervention, such as severe cognitive impairment that interferes with the subject's ability to communicate with interventionists; substantial difficulties in hearing, vision, and verbal expression that disable the participant from communicating effectively while receiving the HomeMed intervention

Sites / Locations

  • University of Rochester Medical CenterRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

All Participants

Arm Description

Outcomes

Primary Outcome Measures

mean time spent on intervention
number of participants who complete a post intervention survey about feasibility
Percentage of participants undergoing deprescribing
Percentage of intervention adherence indicators checked
Percentage of patients who improve in ability to do things that are important before and after intervention
Total number of medications used per participant
Percentage of patients who report a reduction in medication burden
Medication burden will be reported by phone or survey.
Percentage of participants who report a reduction in medication side effect
Side effects will be collected by phone.

Secondary Outcome Measures

Full Information

First Posted
November 17, 2022
Last Updated
April 4, 2023
Sponsor
University of Rochester
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05630144
Brief Title
Deprescribing for Older Adults After Hospital Discharge in Home Health Care
Official Title
Deprescribing for Older Adults After Hospital Discharge in Home Health Care - A Pilot Feasibility Study of the HomeMed Deprescribing Intervention
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 29, 2023 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
September 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Rochester
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to examine the feasibility of providing a medication optimization program to improve patient health outcomes during the transition from hospital to home. This is because the period after hospital discharge is critical to long-term recovery, overall quality of life, and prevention of future hospitalizations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polypharmacy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
All Participants
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
HomeMed
Intervention Description
The HomeMed intervention is a multidisciplinary deprescribing intervention including home visits and team-based telehealth communication (optional). The components included in the HomeMed intervention include home medication review, medication education and provision of tools to assist the patients with medication administration, assessment of deprescribing targets by a trained geriatric clinical pharmacist, communication with the patient's treating primary care provider about deprescribing recommendation, deprescribing implementation (optional), and deprescribing monitoring (optional). Depending on the patient's treating primary care provider's decision on deprescribing and monitoring, the number of home visits ranges from a minimum of three to more with the entire duration of the intervention ranging from approximately 1 to 3 months.
Primary Outcome Measure Information:
Title
mean time spent on intervention
Time Frame
3 months
Title
number of participants who complete a post intervention survey about feasibility
Time Frame
3 months
Title
Percentage of participants undergoing deprescribing
Time Frame
3 months
Title
Percentage of intervention adherence indicators checked
Time Frame
3 months
Title
Percentage of patients who improve in ability to do things that are important before and after intervention
Time Frame
3 months
Title
Total number of medications used per participant
Time Frame
3 months
Title
Percentage of patients who report a reduction in medication burden
Description
Medication burden will be reported by phone or survey.
Time Frame
3 months
Title
Percentage of participants who report a reduction in medication side effect
Description
Side effects will be collected by phone.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Patient Inclusion Criteria: 65 years of age and older currently hospitalized or having been hospitalized in the previous 2 weeks having a discharge disposition of home with a referral to receive HHC services from URMHC, or currently receiving HHC services from URMHC taking more than 10 regular medications daily having a primary care provider who is in the URMC system Ability to self-consent English-speaking Patient Exclusion Criteria: end-of-life prognosis in the following 6 months currently receiving hospice care, end-of-life care, or palliative care conditions that impact the receipt of the intervention, such as severe cognitive impairment that interferes with the subject's ability to communicate with interventionists; substantial difficulties in hearing, vision, and verbal expression that disable the participant from communicating effectively while receiving the HomeMed intervention
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jinjiao Wang, PhD
Phone
585-275-8116
Email
jinjiao_wang@urmc.rochester.edu
Facility Information:
Facility Name
University of Rochester Medical Center
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jinjiao Wang, PhD
Phone
585-275-8116
Email
jinjiao_wang@urmc.rochester.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Deprescribing for Older Adults After Hospital Discharge in Home Health Care

We'll reach out to this number within 24 hrs